白藜芦醇调控LKB1/AMPK通路对乳腺癌细胞增殖、迁移和糖酵解的研究OA
Research of resveratrol on proliferation,migration and glycolysis of breast cancer cells by regulating LKB1/AMPK pathway
目的 探索白藜芦醇通过调控肝激酶B1(LKB1)/腺苷酸活化激酶(AMPK)通路对乳腺癌细胞增殖、迁移和糖酵解的影响及其机制.方法 将人乳腺癌细胞MDA-MB-231分为对照组、低浓度试验组(25 μmol·L-1白藜芦醇)、高浓度实验组(50 μmol·L-1白藜芦醇)和抑制剂组(50 μmol·L-1白藜芦醇和4 μmol·L-1AMPK抑制剂BML-275).用噻唑蓝(MTT)法和Edu染色法测定各组细胞增殖情况;用划痕实验法测定各组细胞迁移情况;用流式细胞仪测定细胞凋亡情况;用葡萄糖含量试剂盒、乳酸含量试剂盒测定各组细胞葡萄糖消耗量、乳酸产生量;用蛋白质印迹法测定各组细胞葡萄糖转运蛋白1(GLUT1)、乳酸脱氢酶A(LDHA)、己糖激酶2(HK2)以及LKB1、AMPK蛋白表达情况.结果 对照组、低、高浓度实验组和抑制剂组的细胞增殖抑制率分别为(0±0)%、(32.27±3.68)%、(56.75±5.82)%和(24.41±3.06)%;Edu 阳性率分别为(52.64±6.95)%、(30.72±4.21)%、(18.86±2.54)%和(41.37±4.88)%;划痕愈合率分别为(34.24±3.82)%、(23.67±2.74)%、(14.85±2.03)%和(29.74±3.42)%;细胞凋亡率分别为(3.04±0.32)%、(21.81±2.64)%、(34.43±3.86)%和(12.67±1.93)%;葡萄糖消耗量分别为(31.74±3.52)、(23.18±2.64)、(14.33±1.67)和(28.27±3.12)μmol·L-1;和乳酸产生量分别为(48.12±4.43)、(31.27±3.75)、(18.85±2.14)和(42.36±4.19)μmol·L-1;GLUT1 相对表达水平分别为 1.14±0.12、0.76±0.08、0.41±0.04 和0.94±0.09;LDHA 相对表达水平分别为 1.32±0.14、0.89±0.09、0.47±0.05和 1.13±0.12;HK2 相对表达水平分别为 0.97±0.09、0.61±0.06、0.34±0.04和 0.86±0.09;LKB1 相对表达水平分别为 0.93±0.10、1.38±0.14、1.75±0.17和 1.12±0.11;AMPK 相对表达水平分别为 1.02±0.11、1.56±0.16、2.04±0.23和1.18±0.13.低、高浓度实验组的上述指标与对照组比较,抑制剂组的上述指标与高浓度实验组比较,在统计学上差异均有统计学意义(均P<0.05).结论 白藜芦醇可能通过激活LKB1/AMPK通路抑制乳腺癌细胞增殖、迁移和糖酵解.
Objective To explore the effects and mechanism of resveratrol on the proliferation,migration and glycolysis of breast cancer cells by regulating the liver kinase B1(LKB1)/AMP activated protein kinase(AMPK)pathway.Methods Human breast cancer MDA-MB-231 cells were divided into four groups:control group,low-concentration experimental group(25 μmol·L-1 resveratrol),high-concentration experimental group(50 μmol·L-1 resveratrol)and inhibitor group(50 μmol·L-1 resveratrol+4 μmol·L-1 AMPK inhibitor BML-275).The cell proliferation of each group was detected by thiazolyl blue(MTT)assay and Edu staining;the cell migration was detected by scratch test;the cell apoptosis was detected by flow cytometry;the glucose consumption and lactic acid production of cells in each group were measured by glucose content kit and lactic acid content kit,respectively;the protein expressions of glucose transporter 1(GLUT1),lactate dehydrogenase A(LDHA),hexokinase 2(HK2),LKB1 and AMPK in each group were detected by Western blot.Results The cell proliferation inhibition rates of control group,low-concentration experimental group,high-concentration experimental group and inhibitor group were(0±0)%,(32.27±3.68)%,(56.75±5.82)%and(24.41±3.06)%,respectively;the Edu-positive rates were(52.64±6.95)%,(30.72±4.21)%,(18.86±2.54)%and(41.37±4.88)%,respectively;the scratch healing rates were(34.24±3.82)%,(23.67±2.74)%,(14.85±2.03)%and(29.74±3.42)%,respectively;the cell apoptosis rates were(3.04±0.32)%,(21.81±2.64)%,(34.43±3.86)%and(12.67±1.93)%,respectively;the glucose consumption levels were(31.74±3.52),(23.18±2.64),(14.33±1.67)and(28.27±3.12)μmol·L-1,respectively;the lactic acid production levels were(48.12±4.43),(31.27±3.75),(18.85±2.14)and(42.36±4.19)μmol·L-1,respectively;the relative expression levels of GLUT1 were 1.14±0.12,0.76±0.08,0.41±0.04 and 0.94±0.09,respectively;the relative expression levels of LDHA were 1.32±0.14,0.89±0.09,0.47±0.05 and 1.13±0.12,respectively;the relative expression levels of HK2 were 0.97±0.09,0.61±0.06,0.34±0.04 and 0.86±0.09,respectively;the relative expression levels of LKB1 were 0.93±0.10,1.38±0.14,1.75±0.17 and 1.12±0.11,respectively;the relative expression levels of AMPK were 1.02±0.11,1.56±0.16,2.04±0.23 and 1.18±0.13,respectively.Compared with control group,the above indicators in the low-and high-concentration experimental groups were statistically significantly different(all P<0.05);compared with the high-concentration experimental group,the above indicators in the inhibitor group were statistically significantly different(all P<0.05).Conclusion Resveratrol may inhibit the proliferation,migration and glycolysis of breast cancer cells by activating the LKB1/AMPK pathway.
李雪曼;刘山;张倬;熊飞
武汉市第三医院心胸及血管外科,湖北 武汉 430000武汉市第三医院心胸及血管外科,湖北 武汉 430000武汉市第三医院心胸及血管外科,湖北 武汉 430000武汉市第三医院心胸及血管外科,湖北 武汉 430000
医药卫生
白藜芦醇肝激酶B1腺苷酸活化激酶乳腺癌增殖迁移糖酵解
resveratrolliver kinase B1AMP activated protein kinasebreast cancerproliferationmigrationglycolysis
《中国临床药理学杂志》 2026 (2)
197-203,7
武汉市中医药科研基金资助项目(WZ24Z01)
评论